Marinus Pharmaceuticals Inc (MRNS)
1.51
+0.06
(+4.14%)
USD |
NASDAQ |
May 03, 16:00
1.515
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Gross Profit Margin (Quarterly): 87.66% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 87.66% |
| September 30, 2023 | 93.80% |
| June 30, 2023 | 93.65% |
| March 31, 2023 | 98.02% |
| December 31, 2022 | 95.92% |
| Date | Value |
|---|---|
| September 30, 2022 | 97.95% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | 85.39% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
85.39%
Minimum
Sep 2021
98.02%
Maximum
Mar 2023
93.20%
Average
93.80%
Median
Sep 2023
Gross Profit Margin (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 94.16% |
| Soligenix Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Macrogenics Inc | 98.22% |
| ADMA Biologics Inc | 42.06% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -214.4% |
| Return on Assets | -66.75% |
| Return on Invested Capital | -102.3% |
| Profit Margin (Quarterly) | -580.9% |
| Operating Margin (Quarterly) | -492.9% |
| Return on Net Operating Assets | -950.9% |